BBB-

New York, USA, September 7, 2026 Insilico Medicine’s AI-driven investigational drug rentosertib has demonstrated potential to reduce measures of...

Tel Aviv, Israel, September 4, 2026 Teva Pharmaceutical Industries Ltd. has received an upgrade to BBB- from BB+ for...